MedTrace Logo

Clinical Utility Evidence for TissueCypher®

NCT05200325 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2023-12-04

No results posted yet for this study

Summary

Cernostics has developed a new diagnostic test, and this study will measure how gastroenterologists and foregut surgeons make diagnostic and treatment decisions when presented with different information in the context of simulated clinical cases. The results of this study could contribute to improved quality of care for patients by encouraging better care practices and adherence to evidence-based guidance. The data from this study will be provided to all participating physicians and submitted to a national journal for publication. The study plans to enroll up to 249 physicians.

Conditions

  • Gastro-Intestinal Disorder
  • Barrett Esophagus

Interventions

OTHER

Educational materials for TissueCypher

These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report.

Sponsors & Collaborators

  • Qure Healthcare, LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-06
Primary Completion
2021-12-15
Completion
2021-12-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05200325 on ClinicalTrials.gov